The 340B Coalition Winter Conference has more than 120 speakers. This page highlights several of the key speakers who are participating in the 50+ sessions. See the agenda for a full list of speakers with bios, and sessions.
Keynote: Donna E. Shalala, Former Secretary, U.S. Department of Health and Human Services
Donna E. Shalala is one of our nation’s leading experts on health care. From
1993 to 2001, Dr. Shalala served as the Secretary of the U.S. Department
of Health and Human Services, under President Clinton. During her
tenure, she was a leading voice advocating for care for all Americans,
especially those living with low incomes, including implementation of
the Children’s Health Insurance Program, the 340B drug pricing program,
and a comprehensive national response to the needs of people living with
HIV and AIDS. She has also served as Assistant Secretary for Policy
Development and Research in the Carter administration and represented
Florida’s 27th District which includes most of Miami.
Dr. Shalala is also one of our nation’s academic leaders, she served as
President of the University of Miami (2001-2015), Chancellor of the
University of Wisconsin-Madison (1987-1993), and President of Hunter
College of the City University of New York (1980-1987). She is an
elected member of the National Academy of Medicine, the National Academy
of Education and the American Academy of Arts and Sciences.
In 2008 President George W. Bush selected Donna Shalala as the recipient
of the Presidential Medal of Freedom, the nation’s highest civilian
award. She was named “America’s Best Leaders” by U.S. News & World
Report (2005), received the Nelson Mandela Award for Health and Human
Rights (2010), and was inducted into the National Women's Hall of Fame
Keynote: Sarah Owermohle, Health Care Reporter, Politico Pro
Sarah Owermohle is a health care reporter for Politico Pro covering drug policy and the industry. She will discuss some of the major drug pricing proposals that will be debated by the new Administration and Congress, their chances for advancement, and the implications for safety-net providers participating in the 340B drug pricing program.
Rear Admiral Krista M. Pedley, Director, Office of Pharmacy Affairs
Krista Pedley is the Director of the Office of Pharmacy Affairs (OPA) in the Healthcare System Bureau, Health Resources & Services Administration (HRSA). Her office administers the 340B drug pricing program, through which more than 700 drug manufacturers provide discounted outpatient drugs to more than 46,700 hospitals and clinics, and more than 24,500 pharmacies. The 340B program spans HHS and focuses on drug pricing transparency and reducing the cost of medications for the country’s most vulnerable safety-net patient populations. She received her Doctor of Pharmacy degree at the University of Pittsburgh in 2000 and her Master of Science in Engineering Management and Systems Engineering, with a Concentration in Crisis, Emergency and Risk Management, from The George Washington University in 2008. She is also a 2011 graduate of the Public Health Leadership Institute Scholar Program.